Status:
COMPLETED
Effectiveness of a Community Pharmacy-based Health Promotion Program on Hypertension in Bangladesh and Pakistan
Lead Sponsor:
Hitotsubashi University
Collaborating Sponsors:
Global Public Health Research Foundation
Conditions:
Blood Pressure
Pharmacy
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
The aim of this multi-country research project is to reduce the blood pressure of individuals with hypertension over a 18-month period in Bangladesh and Pakistan. A cluster randomized controlled trial...
Detailed Description
Globally, hypertension is a leading cause of cardiovascular disease and death. Approximately two-thirds of the world's 1.28 billion hypertensive adults live in low- and middle-income countries (LMICs)...
Eligibility Criteria
Inclusion
- Aged 18 years to 90 years old
- Hypertensive (SBP ≥140 mmHg and DBP ≥90 mmHg and/or taking antihypertensive medications)
- Having suboptimal medication adherence to antihypertensive drugs
- Capable of communicating verbally in local language
- Permanent resident of the study area
- Access to mobile phone
- Consent to participate
- Pharmacists' inclusion criteria include:
- Ensuring a sufficient amount of time to implement intervention on hypertensive participants
- Consent to participate
- Able to operate smartphone or tablet.
Exclusion
- Pregnant and lactating women
- Individuals with advanced medical disease
- Those having cognitive and psychiatric problems,
- Involvement in any other interventional study
- Individuals who are unable to give informed consent.
Key Trial Info
Start Date :
June 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2025
Estimated Enrollment :
3600 Patients enrolled
Trial Details
Trial ID
NCT06148142
Start Date
June 1 2023
End Date
June 30 2025
Last Update
July 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Global Public Health Research Foundation
Dhaka, Bangladesh